The p53 gene was analyzed in tumor specimens obtained from 52 patients with various types of carcinoma of the thyroid gland by a combined molecular and immunocytochemical approach. The histologic types included 37 well-differentiated papillary and follicular carcinomas, 8 poorly differentiated, and 7 undifferentiated carcinomas. The p53 gene was shown to be unaffected in all differentiated tumors by single-strand conformation polymorphism analysis. However, in two out of eight (25%) of poorly differentiated carcinomas and five out of seven (71%) undifferentiated carcinomas, p53 mutations were identified and subsequently characterized by DNA sequencing. One undifferentiated carcinoma displayed two areas with varying degrees of differentiation. The comparative analysis of the p53 gene, in both the more and the less differentiated area of this tumor, clearly showed that the p53 mutation was confined to the latter component of the tumor specimen. These results indicate that mutations of the p53 gene are associated with the most aggressive histologic types of thyroid tumors, such as the undifferentiated carcinoma and, to a certain extent, the poorly differentiated carcinoma, and that the alterations of this gene represent a late genetic event in human thyroid carcinogenesis.
R Donghi, A Longoni, S Pilotti, P Michieli, G Della Porta, M A Pierotti
Title and authors | Publication | Year |
---|---|---|
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation
Lee M, Morris LG |
Oncotarget | 2024 |
Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer
Mu Z, Zhang X, Liang D, Fang J, Chen G, Guo W, Sun D, Sun Y, Kai Z, Huang L, Liang J, Lin Y |
Chinese Journal of Cancer Research | 2024 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, Tirrò E, Di Bella S, Iacono ML, Pantina VD, Porcelli G, Mangiapane LR, Bianca P, Rizzo A, Sciacca E, Pillitteri I, Vella V, Belfiore A, Bongiorno MR, Pistone G, Memeo L, Colarossi L, Giuffrida D, Colarossi C, Vigneri P, Todaro M, Stassi G |
Nature Communications | 2023 |
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer.
de Mello DC, Saito KC, Cristovão MM, Kimura ET, Fuziwara CS |
International journal of molecular sciences | 2023 |
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study.
Razia S, Nakayama K, Yamashita H, Ishibashi T, Ishikawa M, Kanno K, Sato S, Kyo S |
Current oncology (Toronto, Ont.) | 2023 |
Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
Rajabi S, Alix-Panabières C, Alaei AS, Abooshahab R, Shakib H, Ashrafi MR |
Cancers | 2022 |
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.
De Martino M, Esposito F, Capone M, Pallante P, Fusco A |
Cancers | 2022 |
A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
C Romei, R Elisei |
International journal of molecular sciences | 2021 |
Cancer Stemness: p53 at the Wheel
D Ghatak, DD Ghosh, S Roychoudhury |
Frontiers in Oncology | 2021 |
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
J Hu, IJ Yuan, S Mirshahidi, A Simental, SC Lee, X Yuan |
International journal of molecular sciences | 2021 |
The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance
J Zhu, C Liu, D Wang, X Cao, S Wang, Y Liu, J Wang, P Li, Q He |
Frontiers in Oncology | 2021 |
The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer
Z Gong, L Xue, M Wei, Z Liu, AC Vlantis, CA van Hasselt, JY Chan, D Li, X Zeng, MC Tong, GG Chen, S Bekeschus |
Oxidative Medicine & Cellular Longevity | 2021 |
MI‑773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
YL Chen, ZM Zhang, XL Li, YF Tao, SY Wu, F Fang, Y Xie, XM Liao, Li, D Wu, HR Wang, R Zuo, HB Cao, JJ Pan, JJ Yu, Z Zhang, XR Chu, YP Zhang, CX Feng, JW Wang, J Lu, SY Hu, ZH Li, J Pan |
Oncology Letters | 2021 |
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies
M Saqcena, LJ Leandro-Garcia, JL Maag, V Tchekmedyian, GP Krishnamoorthy, PP Tamarapu, V Tiedje, V Reuter, JA Knauf, E de Stanchina, B Xu, XH Liao, S Refetoff, R Ghossein, P Chi, AL Ho, RP Koche, JA Fagin |
Cancer Discovery | 2020 |
Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma
B Xu, T Qin, J Yu, TJ Giordano, MA Sartor, RJ Koenig |
The Journal of biological chemistry | 2020 |
New Therapies for Advanced Thyroid Cancer
D Laha, N Nilubol, M Boufraqech |
Frontiers in Endocrinology | 2020 |
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
S Pellecchia, R Sepe, M Decaussin-Petrucci, C Ivan, M Shimizu, C Coppola, D Testa, GA Calin, A Fusco, P Pallante |
Cancers | 2020 |
Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 expression: A case report with treatment implications and review of literature
M Torrez, RC Braunberger, E Yilmaz, S Agarwal |
Pathology, research and practice | 2020 |
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
H Tabatabaeian, SP Yang, Y Tay |
Cancers | 2020 |
Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis
J Gambardella, A Fiordelisi, G Santulli, M Ciccarelli, FA Cerasuolo, M Sala, E Sommella, P Campiglia, M Illario, G Iaccarino, D Sorriento |
Cancers | 2020 |
Genetic-guided Risk Assessment and Management of Thyroid Cancer
M Xing |
Endocrinology and metabolism clinics of North America | 2019 |
The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician
M Luster, LH Duntas, L Wartofsky |
2019 | |
Genetic alterations in anaplastic thyroid carcinoma
M Rashid, A Agarwal, R Pradhan, N George, N Kumari, M Sabaretnam, G Chand, A Mishra, G Agarwal, SK Mishra |
Indian journal of endocrinology and metabolism | 2019 |
METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition
D Ye, Y Jiang, Y Sun, Y Li, Y Cai, Q Wang, O Wang, E Chen, X Zhang |
Journal of Molecular Endocrinology | 2019 |
The significance of gene mutations across eight major cancer types
P Paul, AK Malakar, S Chakraborty |
Mutation Research/Reviews in Mutation Research | 2019 |
Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
Z Gao, T Lu, H Song, Z Gao, F Ren, P Ouyang, Y Wang, J Zhu, S Zhou, X He |
Medical science monitor : international medical journal of experimental and clinical research | 2019 |
Coding Molecular Determinants of Thyroid Cancer Development and Progression
V Valvo, C Nucera |
Endocrinology and metabolism clinics of North America | 2018 |
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
C Romei, A Tacito, E Molinaro, P Piaggi, V Cappagli, L Pieruzzi, A Matrone, D Viola, L Agate, L Torregrossa, C Ugolini, F Basolo, LD Napoli, M Curcio, R Ciampi, G Materazzi, P Vitti, R Elisei |
Oncology Letters | 2018 |
Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway
H Zhang, N Hu |
Molecular medicine reports | 2018 |
Genetic aberrations and alterations in signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer
S Saini, AV Maker, KD Burman, BS Prabhakar |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2018 |
A Review of Driver Genetic Alterations in Thyroid Cancers
Fatemeh Khatami, Seyed Mohammad Tavangar |
Iranian Journal of Pathology | 2018 |
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
E Molinaro, C Romei, A Biagini, E Sabini, L Agate, S Mazzeo, G Materazzi, S Sellari-Franceschini, A Ribechini, L Torregrossa, F Basolo, P Vitti, R Elisei |
Nature Reviews Endocrinology | 2017 |
ZCCHC12, a novel oncogene in papillary thyroid cancer
O Wang, Z Zheng, Q Wang, Y Jin, W Jin, Y Wang, E Chen, X Zhang |
Journal of Cancer Research and Clinical Oncology | 2017 |
Diagnostic Molecular Pathology
RC Arcenas |
Diagnostic Molecular Pathology | 2017 |
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
B Bonhomme, Y Godbert, G Perot, AA Ghuzlan, S Bardet, G Belleannée, L Crinière, CD Cao, G Fouilloux, S Guyetant, A Kelly, S Leboulleux, C Buffet, E Leteurtre, JJ Michels, F Tissier, ME Toubert, M Wassef, C Pinard, I Hostein, I Soubeyran |
Thyroid | 2017 |
Oncogenesis of Thyroid Cancer
Enas Younis |
Asian Pacific Journal of Cancer Prevention | 2017 |
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA
DS Duick, RA Levine, MA Lupo |
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA | 2017 |
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden, D Biase, A Pession, T Giovanni |
Histopathology | 2017 |
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis
YS Song, CK Jung, KC Jung, YJ Park, JK Won |
Journal of Korean Medical Science | 2017 |
Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies
NA Cipriani, S Agarwal, D Dias-Santagata, WC Faquin, PM Sadow |
Thyroid | 2017 |
The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration
S Mertsch, OH Krämer |
Cytokine & Growth Factor Reviews | 2017 |
Glycolysis-related protein expression in thyroid cancer
JH Nahm, HM Kim, JS Koo |
Tumor Biology | 2017 |
New perspectives in the diagnosis of thyroid follicular lesions
E Baldini, S Sorrenti, F Tartaglia, A Catania, A Palmieri, D Pironi, A Filippini, S Ulisse |
International journal of surgery (London, England) | 2017 |
Gene master regulators of papillary and anaplastic thyroid cancers
DA Iacobas, NY Tuli, S Iacobas, JK Rasamny, A Moscatello, J Geliebter, RK Tiwari |
Oncotarget | 2017 |
Genomic and Transcriptomic Hallmarks of Poorly-Differentiated and Anaplastic Thyroid Cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A. Knauf, Ronak Shah, Snjezana Dogan, Julio Ricarte-Filho, Gnana P. Krishnamoorthy, Bin Xu, Nikolaus Schultz, Michael Berger, Chris Sander, Barry Taylor, Ronald Ghossein, Ian Ganly, James Fagin |
Journal of Clinical Investigation | 2016 |
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
S Narayanan, AD Colevas |
Current Treatment Options in Oncology | 2016 |
Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation
Y Shetzer, A Molchadsky, V Rotter |
Cold Spring Harbor Perspectives in Medicine | 2016 |
Expression of glutamine metabolism-related proteins in thyroid cancer
HM Kim, YK Lee, JS Koo |
Oncotarget | 2016 |
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer
S Latteyer, V Tiedje, K König, S Ting, LC Heukamp, L Meder, KW Schmid, D Führer, LC Moeller |
Endocrine | 2016 |
Molecular genetics of thyroid cancer
M Rebaї, A Rebaї |
Genetics Research | 2016 |
Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
L Zhang, M Boufraqech, R Lake, E Kebebew |
Oncotarget | 2016 |
Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy
S Sorrenti, E Baldini, F Tartaglia, A Catania, S Arcieri, D Pironi, PG Calò, A Filippini, S Ulisse |
Aging clinical and experimental research | 2016 |
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer
S Latteyer, V Tiedje, K König, S Ting, LC Heukamp, L Meder, KW Schmid, D Führer, LC Moeller |
Endocrine | 2016 |
Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma
QX Wang, ED Chen, YF Cai, YL Zhou, ZC Zheng, YH Wang, YX Jin, WX Jin, XH Zhang, OC Wang |
OncoTargets and therapy | 2016 |
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
J Lu, S Guan, Y Zhao, Y Yu, Y Wang, Y Shi, X Mao, KL Yang, W Sun, X Xu, JS Yi, T Yang, J Yang, JG Nuchtern |
Oncotarget | 2016 |
Follicular cell-derived thyroid cancer
H Dralle, A Machens, J Basa, V Fatourechi, S Franceschi, ID Hay, YE Nikiforov, F Pacini, JL Pasieka, SI Sherman |
Nature Reviews Disease Primers | 2015 |
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.
Grassi ES, Vezzoli V, Negri I, Lábadi Á, Fugazzola L, Vitale G, Persani L |
Oncotarget | 2015 |
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Zhang L, Zhang Y, Mehta A, Boufraqech M, Davis S, Wang J, Tian Z, Yu Z, Boxer MB, Kiefer JA, Copland JA, Smallridge RC, Li Z, Shen M, Kebebew E |
Oncotarget | 2015 |
Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid
GX Tong, K Mody, Z Wang, D Hamele-Bena, MN Nikiforova, YE Nikiforov |
Endocrine Pathology | 2015 |
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Lisa Zhang, Yaqin Zhang, Amit Mehta, Myriem Boufraqech, Sean Davis, Jing Wang, Ze Tian, Zhiya Yu, Matthew B Boxer, Jeffrey A Kiefer, John A Copland, Robert C Smallridge, Zhuyin Li, Min Shen, Electron Kebebew |
Oncotarget | 2015 |
Zn(II)-curc targets p53 in thyroid cancer cells
A Garufi, V D'Orazi, A Crispini, G D'Orazi |
International journal of oncology | 2015 |
Molecular approaches to thyroid cancer diagnosis
SJ Hsiao, Y Nikiforov |
Endocrine Related Cancer | 2014 |
Immunohistochemical Expression of Potential Therapeutic Targets in Canine Thyroid Carcinoma
M Campos, R Ducatelle, HS Kooistra, G Rutteman, L Duchateau, I Polis, S Daminet |
Journal of Veterinary Internal Medicine | 2014 |
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
R Parenti, L Salvatorelli, G Magro |
International Journal of Endocrinology | 2014 |
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
P Raman, RJ Koenig |
Nature Reviews Endocrinology | 2014 |
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
CS Fuziwara, ET Kimura |
International Journal of Endocrinology | 2014 |
The paradigm of mutant p53-expressing cancer stem cells and drug resistance
Y Shetzer, H Solomon, G Koifman, A Molchadsky, S Horesh, V Rotter |
Carcinogenesis | 2014 |
An update on molecular biology of thyroid cancers
O Omur, Y Baran |
Critical Reviews in Oncology/Hematology | 2014 |
p53: The barrier to cancer stem cell formation
R Aloni-Grinstein, Y Shetzer, T Kaufman, V Rotter |
FEBS Letters | 2014 |
Association of P53 (−16ins-Pro) Haplotype with the Decreased Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients
R Dehghan, MA Feizi, N Pouladi, E Babaei, V Montazeri, A Fakhrjoo, A Sedaei, P Azarfam, M Nemati |
Pathology & Oncology Research | 2014 |
Targeting RAS/MAPK/ERK and PI3K/AKT/mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma
Z Milosevic, M Pesic, T Stankovic, J Dinic, Z Milovanovic, J Stojsic, R Dzodic, N Tanic, J Bankovic |
Translational Research | 2014 |
Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer
HH Patel, N Goyal, D Goldenberg |
Annals of Medicine | 2014 |
Is Poorly Differentiated Thyroid Cancer Poorly Characterized?
KD Burman |
The Journal of clinical endocrinology and metabolism | 2014 |
Tumour suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
Angelo Ferraro, Filippo Schepis, vincenza leone, Antonella Federico, Eleonora Borbone, Pierlorenzo Pallante, Maria Teresa Berlingieri, Gennaro Chiapetta, Mario Monaco, Claudio Arra, Giuseppe Palma, Dario Palmieri, Giancarlo Troncone, Lorenzo Chiariotti, Massimo Santoro, Alfredo Fusco |
2013 | |
Molecular pathogenesis and mechanisms of thyroid cancer
M Xing |
Nature Reviews Cancer | 2013 |
Genetics and epigenetics of sporadic thyroid cancer
D Vu-Phan, RJ Koenig |
Molecular and Cellular Endocrinology | 2013 |
Deregulation of microRNA expression in thyroid neoplasias
P Pallante, S Battista, GM Pierantoni, A Fusco |
Nature Reviews Endocrinology | 2013 |
Progress in molecular-based management of differentiated thyroid cancer
M Xing, BR Haugen, M Schlumberger |
The Lancet | 2013 |
eLS
YC Chang, YH Yu, LM Chuang |
Encyclopedia of Life Sciences | 2013 |
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literature
R Granata, L Locati, L Licitra |
Current Opinion in Oncology | 2013 |
Genetic mutations, molecular markers and future directions in research
KN Patel |
Oral Oncology | 2013 |
Recent progress of genome study for anaplastic thyroid cancer
J Lee, JA Hwang, EK Lee |
Genomics & Informatics | 2013 |
Essential genes in thyroid cancers: focus on fascin
H Samimi, MZ Dizaji, M Ghadami, AS Fazeli, P Khashayar, M Soleimani, B Larijani, V Haghpanah |
Journal of Diabetes & Metabolic Disorders | 2013 |
The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells
F Guerrieri, S Piconese, C Lacoste, V Schinzari, B Testoni, Y Valogne, S Gerbal-Chaloin, D Samuel, C Bréchot, J Faivre, M Levrero |
Cell Death and Disease | 2013 |
p53 antibody: is it an indicator of dedifferentiated thyroid cancer?
Z Hasbek, B Turgut, T Erselcan |
Annals of Nuclear Medicine | 2013 |
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
MN Nikiforova, AI Wald, S Roy, MB Durso, YE Nikiforov |
The Journal of clinical endocrinology and metabolism | 2013 |
Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma
YM Lee, JB Lee |
J INT MED RES | 2013 |
Molecular Pathology and Diagnostics of Cancer
D Coppola |
2013 | |
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
A Guerra, VD Crescenzo, A Garzi, M Cinelli, C Carlomagno, M Tonacchera, P Zeppa, M Vitale |
BMC surgery | 2013 |
Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature
VD Crescenzo, A Garzi, F Petruzziello, M Cinelli, L Catalano, P Zeppa, M Vitale |
BMC surgery | 2013 |
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
Vladimir Ratushny, Michael Gober, Ryan Hick, Todd Ridky, John Seykora |
Journal of Clinical Investigation | 2012 |
Poorly Differentiated Thyroid Carcinoma: An Incubating Entity
PM Sadow, WC Faquin |
Frontiers in Endocrinology | 2012 |
Inflammation in thyroid oncogenesis
F Liotti, C Visciano, RM Melillo |
American journal of cancer research | 2012 |
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
RC Smallridge, KB Ain, SL Asa, KC Bible, JD Brierley, KD Burman, E Kebebew, NY Lee, YE Nikiforov, MS Rosenthal, MH Shah, AR Shaha, RM Ass |
Thyroid | 2012 |
Recent advances in molecular diagnosis of thyroid cancer
I Legakis, K Syrigos |
Journal of Thyroid Research | 2011 |
Molecular genetics and diagnosis of thyroid cancer
YE Nikiforov, MN Nikiforova |
Nature Reviews Endocrinology | 2011 |
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas
L Lavra, C Rinaldo, A Ulivieri, E Luciani, P Fidanza, L Giacomelli, C Bellotti, A Ricci, M Trovato, S Soddu, A Bartolazzi, S Sciacchitano |
PloS one | 2011 |
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma
G Gauchotte, C Philippe, S Lacomme, B Léotard, MP Wissler, L Allou, B Toussaint, M Klein, JM Vignaud, A Bressenot |
Pathology | 2011 |
Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma
JH Chen, WC Faquin, RV Lloyd, V Nosé |
Modern Pathology | 2011 |
Abnormal Nuclear Structures (Micronuclei, Nuclear Blebs, Strings, and Pockets) in a Case of Anaplastic Giant Cell Carcinoma of the Thyroid: An Immunohistochemical and Ultrastructural Study
RA Caruso, F Fedele, C Crisafulli, D Paparo, A Parisi, R Lucianò, V Cavallari |
Ultrastructural Pathology | 2011 |
Thyroid Cancer
J Machac |
Thyroid Cancer | 2011 |
Well differentiated follicular thyroid neoplasia: Impact of molecular and technological advances on detection, monitoring and treatment
AG Gianoukakis, SM Giannelli, WA Salameh, LW McPhaul |
Molecular and Cellular Endocrinology | 2011 |
Poorly differentiated thyroid carcinoma in a 9-year-old boy: case report
YL Wu, WH Ting, SL Wey, CK Chen, CY Huang, SP Cheng, YJ Lee |
Journal of Pediatric Endocrinology and Metabolism | 2011 |
Gene expression profile of human thyroid cancer in relation to its mutational status
D Rusinek, S Szpak-Ulczok, B Jarzab |
Journal of Molecular Endocrinology | 2011 |
Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
P Soares, J Lima, A Preto, P Castro, J Vinagre, R Celestino, JP Couto, H Prazeres, C Eloy, V Máximo, M Sobrinho-Simões |
Current genomics | 2011 |
Cytologic and molecular diagnosis of thyroid cancers : Is it time for routine reflex testing?
LA Hassell, EM Gillies, ST Dunn |
Cancer Cytopathology | 2011 |
Poorly differentiated thyroid carcinoma: an evolving entity
G Garcia-Rostan, M Sobrinho-Simões |
Diagnostic Histopathology | 2011 |
The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas
L Lavra, C Rinaldo, A Ulivieri, E Luciani, P Fidanza, L Giacomelli, C Bellotti, A Ricci, M Trovato, S Soddu, A Bartolazzi, S Sciacchitano, HT Nguyen |
PloS one | 2011 |
Thyroid cancer: current molecular perspectives
F Giusti, A Falchetti, F Franceschelli, F Marini, A Tanini, ML Brandi |
Journal of Oncology | 2010 |
A Practical Manual of Thyroid and Parathyroid Disease
KN Patel, B Singh |
A Practical Manual of Thyroid and Parathyroid Disease | 2010 |
Changes of Apoptosis, p53, and bcl-2 by Irradiation in Poorly Differentiated Thyroid Carcinoma Cell Lines: A Prognostic Marker for the Prospect of Therapeutic Success?
F Pohl, J Grosse, D Grimm, G Brockhoff, K Westphal, J Moosbauer, O Koelbl, M Infanger, C Eilles, J Schoenberger |
Thyroid | 2010 |
Thyroid cancer and inflammation
V Guarino, MD Castellone, E Avilla, RM Melillo |
Molecular and Cellular Endocrinology | 2010 |
Medullary, Anaplastic, and Metastatic Cancers of the Thyroid
SC Pitt, JF Moley |
Seminars in Oncology | 2010 |
Molecular pathogenesis of follicular cell derived thyroid cancers
R Parameswaran, S Brooks, GP Sadler |
International Journal of Surgery | 2010 |
Molecular and Other Novel Advances in Treatment of Metastatic Epithelial and Medullary Thyroid Cancers
D Tai, D Poon |
Journal of Oncology | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Poorly Differentiated Thyroid Carcinoma: 5 Years after the 2004 WHO Classification of Endocrine Tumours
M Volante, M Papotti |
Endocrine Pathology | 2009 |
Thyroid tumors: novel insights from proteomic studies
G Damante, A Scaloni, G Tell |
Expert Review of Proteomics | 2009 |
Thyroid Papillary Carcinoma with Micropapillary and Hobnail Growth Pattern: A Histological Variant with Intermediate Malignancy?
U Motosugi, SI Murata, K Nagata, M Yasuda, M Shimizu |
Thyroid | 2009 |
Poorly Differentiated Thyroid Carcinoma
M Bongiovanni, PM Sadow, WC Faquin |
Advances in Anatomic Pathology | 2009 |
RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact
M Volante, I Rapa, M Gandhi, G Bussolati, D Giachino, M Papotti, YE Nikiforov |
The Journal of clinical endocrinology and metabolism | 2009 |
Endocrine Pathology:
RV Lloyd |
2009 | |
Molecular pathology of thyroid cancer: diagnostic and clinical implications
JA Fagin, N Mitsiades |
Best Practice & Research Clinical Endocrinology & Metabolism | 2008 |
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
RC Smallridge, LA Marlow, JA Copland |
Endocrine Related Cancer | 2008 |
Poorly Differentiated Thyroid Carcinoma: Diagnostic Features and Controversial Issues
M Volante, I Rapa, M Papotti |
Endocrine Pathology | 2008 |
Clinical Significance of P53 Protein Expression in Papillary Thyroid Carcinoma
N Morita, Y Ikeda, H Takami |
World Journal of Surgery | 2008 |
The Molecular Basis of Cancer
A Bafico, L Grumolato, SA Aaronson |
The Molecular Basis of Cancer | 2008 |
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis
MN Nikiforova, YE Nikiforov |
Expert Review of Molecular Diagnostics | 2008 |
Intragenic Mutations in Thyroid Cancer
M Sobrinho-Simões, V Máximo, AS Rocha, V Trovisco, P Castro, A Preto, J Lima, P Soares |
Endocrinology & Metabolism Clinics of North America | 2008 |
Cancers anaplasiques de la thyroïde
JL Wemeau, CD Cao |
Annales d'Endocrinologie | 2008 |
Clinical Impact of Molecular Analysis on Thyroid Cancer Management
VB Wreesmann, B Singh |
Surgical oncology clinics of North America | 2008 |
Thyroid adenomatous nodule with bizarre nuclei: A case report and mutation analysis of the p53 gene
K Sato, Y Shimode, M Hirokawa, Y Ueda, S Katsuda |
Pathology - Research and Practice | 2008 |
Application of Immunohistochemistry to Thyroid Neoplasms
S Fischer, SL Asa |
Archives of pathology & laboratory medicine | 2008 |
Transcriptional Profile of Ki-Ras-Induced Transformation of Thyroid Cells
R Visconti, A Federico, V Coppola, F Pentimalli, MT Berlingieri, P Pallante, M Kruhoffer, TF Orntoft, A Fusco |
Cancer Investigation | 2007 |
Establishment and characterization of cell lines from three human thyroid carcinomas: Responses to all-trans-retinoic acid and mutations in the BRAF gene
CS Koh, JL Ku, SY Park, KH Kim, JS Choi, IJ Kim, JH Park, SK Oh, JK Chung, JH Lee, WH Kim, CW Kim, BY Cho, JG Park |
Molecular and Cellular Endocrinology | 2007 |
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
C Zafon, G Obiols, J Castellví, N Tallada, JA Baena, R Simó, J Mesa |
Histopathology | 2007 |
Clinical, Histopathological, and Molecular Characteristics of Papillary Thyroid Microcarcinoma
DJ Lim, KH Baek, YS Lee, WC Park, MK Kim, MI Kang, HM Jeon, JM Lee, B Yun-Cha, KW Lee, HY Son, SK Kang |
Thyroid | 2007 |
Anaplastic Carcinoma of the Thyroid Arising More Often from Follicular Carcinoma than Papillary Carcinoma
HM Wang, YW Huang, JS Huang, CH Wang, VC Kok, CM Hung, HM Chen, CY Tzen |
Annals of Surgical Oncology | 2007 |
RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy
M Nakashima, N Takamura, H Namba, V Saenko, S Meirmanov, N Matsumoto, T Hayashi, S Maeda, I Sekine |
Human Pathology | 2007 |
Molecular and Genotypic Characterization of Human Thyroid Follicular Cell Carcinoma–Derived Cell Lines
AM Meireles, A Preto, AS Rocha, AP Rebocho, V Máximo, I Pereira-Castro, S Moreira, T Feijão, T Botelho, R Marques, V Trovisco, L Cirnes, C Alves, S Velho, P Soares, M Sobrinho-Simões |
Thyroid | 2007 |
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
R Visone, P Pallante, A Vecchione, R Cirombella, M Ferracin, A Ferraro, S Volinia, S Coluzzi, V Leone, E Borbone, CG Liu, F Petrocca, G Troncone, GA Calin, A Scarpa, C Colato, G Tallini, M Santoro, CM Croce, A Fusco |
Oncogene | 2007 |
Differentiated thyroid cancer
M Freeby, RJ McConnell |
Community Oncology | 2007 |
RET oncogene amplification in thyroid cancer: Correlations with radiation-associated, high-grade malignancy, and genomic instability
M Nakashima, N Takamura, H Namba, VA Saenko, K Suzuki, S Meirmanov, T Hayashi, I Sekine |
International Congress Series | 2007 |
Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis
T Karlidag, B Cobanoglu, E Keles, HC Alpay, I Ozercan, I Kaygusuz, S Yalcin, O Sakallioglu |
American Journal of Otolaryngology | 2007 |
Molecular Pathology in Clinical Practice
DG Leonard, A Bagg, AM Caliendo, KL Kaul, VM Deerlin |
2007 | |
Surgery of the Thyroid and Parathyroid Glands
D Oertli, R Udelsman |
2007 | |
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo, S Ezzat, SL Asa |
Nature Reviews Cancer | 2006 |
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions
K Pavelić, RA Dedivitis, S Kapitanović, T Čačev, CR Guirado, D Danić, S Radošević, K Brkić, B Pegan, Š Križanac, Z Kusić, Š Spaventi, M Bura |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2006 |
Poorly Differentiated Follicular Thyroid Carcinoma Expressing p53 and Presenting as Metastases Only to the Brain
TW Furlanetto, MR Cerski, A Schmidt, AP Paludo, AA Rosa |
The Endocrinologist | 2006 |
Pathology and genetics of thyroid carcinoma
RA DeLellis |
Journal of Surgical Oncology | 2006 |
2-Methoxyestradiol Induces Apoptosis in Cultured Human Anaplastic Thyroid Carcinoma Cells
P Roswall, S Bu, K Rubin, M Landström, NE Heldin |
Thyroid | 2006 |
Genetic Considerations in Thyroid Cancer
KN Patel, B Singh |
Cancer control : journal of the Moffitt Cancer Center | 2006 |
Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas
D Corapcioglu, SD Sak, T Delibasi, V Tonyukuk, N Kamel, AR Uysal, S Kocak, S Aydintug, G Erdogan |
Journal of Translational Medicine | 2006 |
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
TJ Giordano, R Kuick, DG Thomas, DE Misek, M Vinco, D Sanders, Z Zhu, R Ciampi, M Roh, K Shedden, P Gauger, G Doherty, NW Thompson, S Hanash, RJ Koenig, YE Nikiforov |
Oncogene | 2005 |
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
P Pallante, MT Berlingieri, G Troncone, M Kruhoffer, TF Orntoft, G Viglietto, A Caleo, I Migliaccio, M Decaussin-Petrucci, M Santoro, L Palombini, A Fusco |
British Journal of Cancer | 2005 |
Immunohistochemical Characterization of Parafollicular Cell Adenoma, Medullary Carcinoma and Follicular Adenocarcinoma in Thyroid of Horses
T OYAMADA, H UEKI, H KOWATARI, P CHUN-HO, Y KATAYAMA, M OIKAWA, H YOSHIKAWA |
Journal of Equine Science | 2005 |
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due toBRAF andp53 mutations
RM Quiros, HG Ding, P Gattuso, RA Prinz, X Xu |
Cancer | 2005 |
Anaplastic thyroid cancer and hyperthyroidism
Vijay Kumar, Bruno Blanchon, Xin Gu, Marjorie Fowler, David Scarborough, Cherie Ann Nathan, Subhashini Yaturu |
Endocrine Pathology | 2005 |
Molecular Carcinogenesis and the Molecular Biology of Human Cancer: Molecular Biology and Clinical Aspects
J Lillehaug, JE Varhaug, Ø Fluge |
Molecular Carcinogenesis and the Molecular Biology of Human Cancer: Molecular Biology and Clinical Aspects | 2005 |
Molecular Basis of Thyroid Cancer
NR Farid |
2005 | |
Mitogenic Effects of the Up-Regulation of Minichromosome Maintenance Proteins in Anaplastic Thyroid Carcinoma
T Guida, G Salvatore, P Faviana, R Giannini, G Garcia-Rostan, L Provitera, F Basolo, A Fusco, F Carlomagno, M Santoro |
The Journal of clinical endocrinology and metabolism | 2005 |
Gene therapy for thyroid cancer
L Barzon, M Pacenti, M Boscaro, G Palù |
Expert Opinion on Biological Therapy | 2004 |
BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment
S Begum, E Rosenbaum, R Henrique, Y Cohen, D Sidransky, WH Westra |
Modern Pathology | 2004 |
Epithelioid haemangiosarcoma of the thyroid gland. Report of six cases from a non-Alpine region
A Ryska, M Ludvikova, P Szepe, A Boor |
Histopathology | 2004 |
Anaplastic Thyroid Carcinoma with Humoral Hypercalcemia of Malignancy (HHM): An Autopsy Case Report
H IWAI, Y OHNO, N AOKI |
Endocrine Journal | 2004 |
Implications of Prognostic Factors and Risk Groups in the Management of Differentiated Thyroid Cancer:
AR Shaha |
The Laryngoscope | 2004 |
BRAF alterations are associated with complex mutational profiles in malignant melanoma
M Daniotti, M Oggionni, T Ranzani, V Vallacchi, V Campi, DD Stasi, GD Torre, F Perrone, C Luoni, S Suardi, M Frattini, S Pilotti, A Anichini, G Tragni, G Parmiani, MA Pierotti, M Rodolfo |
Oncogene | 2004 |
Practical Markers Used in the Diagnosis of Endocrine Tumors:
LA Erickson, RV Lloyd |
Advances in Anatomic Pathology | 2004 |
Genetic Alterations Involved in the Transition from Well-Differentiated to Poorly Differentiated and Anaplastic Thyroid Carcinomas
YE Nikiforov |
Endocrine Pathology | 2004 |
Definition of Poorly Differentiated Carcinoma of the Thyroid: The Japanese Experience
A Sakamoto |
Endocrine Pathology | 2004 |
Cyclooxygenase-2 expression in thyroid neoplasms
Y Ito, H Yoshida, K Nakano, Y Takamura, A Miya, K Kobayashi, T Yokozawa, F Matsuzuka, N Matsuura, K Kuma, A Miyauchi |
Histopathology | 2003 |
Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy
SM Wiseman, TR Loree, NR Rigual, WL Hicks, WG Douglas, GR Anderson, DL Stoler |
Head & Neck | 2003 |
Expression of RET in follicular cell-derived tumors of the thyroid gland: Prevalence and implication of morphological type
M Inaba, S Umemura, H Satoh, Y Abe, K Kurokawa, H Sakai, RY Osamura |
Pathology International | 2003 |
Is atypical follicular adenoma of the thyroid a preinvasive malignancy?
CY Tzen, YW Huang, YS Fu |
Human Pathology | 2003 |
Endocrine Surgery
P Hellman |
Endocrine Surgery: Its Physiology and Function | 2003 |
Hypermethylation of the CDKN2/p16INK4A Promotor in Thyroid Carcinogenesis
C Boltze, S Zack, C Quednow, S Bettge, A Roessner, R Schneider-Stock |
Pathology - Research and Practice | 2003 |
KAI1 Expression in Thyroid Neoplasms: Its Linkage with Clinicopathologic Features in Papillary Carcinoma
Y Ito, H Yoshida, T Uruno, K Nakano, Y Takamura, A Miya, K Kobayashi, T Yokozawa, F Matsuzuka, K Kuma, A Miyauchi |
Pathology - Research and Practice | 2003 |
Surgical Oncology
TJ Saclarides, KW Millikan, CV Godellas |
Surgical Oncology | 2003 |
TP53 , p14ARF , p16INK4a and H- ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses: TP53 , p14ARF and p16INK4a Deregulation in ITAC
F Perrone, M Oggionni, S Birindelli, S Suardi, S Tabano, R Romano, ML Moiraghi, G Bimbi, P Quattrone, G Cantu, MA Pierotti, L Licitra, S Pilotti |
International Journal of Cancer | 2003 |
Clinical Significance of Molecular Expression Profiles of Hürthle Cell Tumors of the Thyroid Gland Analyzed via Tissue Microarrays
A Hoos, A Stojadinovic, B Singh, ME Dudas, DH Leung, AR Shaha, JP Shah, MF Brennan, C Cordon-Cardo, R Ghossein |
The American Journal of Pathology | 2002 |
Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours
BR Haugen, WW Woodmansee, MT McDermott |
Clinical Endocrinology | 2002 |
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
V Zuco, R Supino, SC Righetti, L Cleris, E Marchesi, C Gambacorti-Passerini, F Formelli |
Cancer Letters | 2002 |
Apoptosis: Life Through Planned Cellular Death Regulating Mechanisms, Control Systems, and Relations with Thyroid Diseases
F Lumachi, S Basso |
Thyroid | 2002 |
Genome-wide appraisal of thyroid cancer progression
VB Wreesmann, RA Ghossein, SG Patel, CP Harris, EA Schnaser, AR Shaha, RM Tuttle, JP Shah, PH Rao, B Singh |
The American Journal of Pathology | 2002 |
P63 Expression in Papillary and Anaplastic Carcinomas of the Thyroid Gland: Lack of an Oncogenetic Role in Tumorigenesis and Progression
A Preto, JS Reis-Filho, S Ricardo, P Soares |
Pathology - Research and Practice | 2002 |
Differential interaction of Enigma protein with the two RET isoforms
MG Borrello, E Mercalli, C Perego, D Degl'Innocenti, S Ghizzoni, E Arighi, B Eroini, MG Rizzetti, MA Pierotti |
Biochemical and Biophysical Research Communications | 2002 |
Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells
Sung Hwa Chung, Naoyoshi Onoda, Tetsuro Ishikawa, Kana Ogisawa, Chiemi Takenaka, Yoshihisa Yano, Fumihiko Hato, Kosei Hirakawa |
Japanese journal of cancer research : Gann | 2002 |
ONYX-015, an E1B Gene-Defective Adenovirus, Induces Cell Death in Human Anaplastic Thyroid Carcinoma Cell Lines
G Portella, S Scala, D Vitagliano, G Vecchio, A Fusco |
The Journal of clinical endocrinology and metabolism | 2002 |
Molecular Pathobiology of Thyroid Neoplasms
G Tallini |
Endocrine Pathology | 2002 |
Peroxisome Proliferator‐activated Receptor Gamma Activation Induces Cell Cycle Arrest via the p53‐independent Pathway in Human Anaplastic Thyroid Cancer Cells
Chung SH, Onoda N, Ishikawa T, Ogisawa K, Takenaka C, Yano Y, Hato F, Hirakawa K |
Japanese journal of cancer research : Gann | 2002 |
Bax expression in benign and malignant thyroid tumours: Dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma
S Hermann, I Sturm, A Mrozek, B Klosterhalfen, S Hauptmann, B D�rken, PT Daniel |
International Journal of Cancer | 2001 |
Solid Variant of Papillary Thyroid Carcinoma
YE Nikiforov, LA Erickson, MN Nikiforova, CM Caudill, RV Lloyd |
The American Journal of Surgical Pathology | 2001 |
GENETIC MARKERS IN THYROID NEOPLASIA
E Puxeddu, JA Fagin |
Endocrinology & Metabolism Clinics of North America | 2001 |
Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features
S Horie, H Maeta, K Endo, T Ueta, K Takashima, T Terada |
Pathology International | 2001 |
Thyroid cancer
O Gimm |
Cancer Letters | 2001 |
Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath Tumors
S Birindelli, F Perrone, M Oggionni, C Lavarino, B Pasini, B Vergani, GN Ranzani, MA Pierotti, S Pilotti |
Laboratory Investigation | 2001 |
P53 mutations in thyroid carcinoma: Tidings from an old foe
NR Farid |
Journal of Endocrinological Investigation | 2001 |
Thyroid Carcinoma Is Characterized by Genomic Instability: Evidence from p53 Mutations
B Shahedian, Y Shi, M Zou, NR Farid |
Molecular Genetics and Metabolism | 2001 |
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
GD Torre, B Pasini, S Frigerio, R Donghi, D Rovini, D Delia, G Peters, TJ Huot, G Bianchi-Scarra, F Lantieri, M Rodolfo, G Parmiani, MA Pierotti |
British Journal of Cancer | 2001 |
Paucicellular Variant of Anaplastic Thyroid Carcinoma: Report of Two Cases
JC Canos, A Serrano, X Matias-Guiu |
Endocrine Pathology | 2001 |
The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: Report of a case
K Shingu, S Kobayashi, S Yokoyama, M Fujimori, K Asanuma, K Ito, Y Hama, M Maruyama, R Kusama, J Amano |
Surgery Today | 2000 |
Allelotyping of anaplastic thyroid carcinoma: Frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q
Y Kitamura, K Shimizu, S Tanaka, K Ito, M Emi |
Genes, Chromosomes and Cancer | 2000 |
Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas
KM la Perle, SM Jhiang, CC Capen |
The American Journal of Pathology | 2000 |
Oncogenes and Thyroid Cancer
G Vecchio, M Santoro |
Clinical Chemistry and Laboratory Medicine | 2000 |
Insular and Anaplastic Carcinoma of the Thyroid
K Lam, C Lo, K Chan, K Wan |
Annals of Surgery | 2000 |
Anaplastic Changes Associated with p53 Gene Mutation in Differentiated Thyroid Carcinoma After Insufficient Radioactive Iodine (131I) Therapy
N Sera, K Ashizawa, T Ando, A Ide, Y Abe, T Usa, T Tominaga, E Ejima, T Hayashi, I Shimokawa, K Eguchi |
Thyroid | 2000 |
Molecular Alterations Involving p53 Codons 167 and 183 in Papillary Thyroid Carcinomas from Chernobyl-Contaminated Regions of Belarus
AV Pisarchik, G Ermak, NA Kartel, J Figge |
Thyroid | 2000 |
In SituApoptosis in the Thyroid
TT Sreelekha, VM Pradeep, K Vijayalakshmi, A Belthazar, VG Chellam, MB Nair, MR Pillai |
Thyroid | 2000 |
Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21
KY Lam, CY Lo, KW Chan, KY Wan |
Annals of Surgery | 2000 |
Detection of Numerical Chromosome Anomalies in Interphase Cells of Benign and Malignant Thyroid Lesions Using Fluorescence In Situ Hybridization
N Barril, AB Carvalho-Sales, EH Tajara |
Cancer Genetics and Cytogenetics | 2000 |
Molecular pathogenesis of thyroid nodules and cancer
F Moretti, S Nanni, A Pontecorvi |
Best Practice & Research Clinical Endocrinology & Metabolism | 2000 |
Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy
ME Barcus, CN Powers |
Endocrine Pathology | 2000 |
Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects
N J Sarlis |
Reviews in Endocrine and Metabolic Disorders | 2000 |
Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features
G Bunone, P Vigneri, L Mariani, S Butó, P Collini, S Pilotti, MA Pierotti, I Bongarzone |
The American Journal of Pathology | 1999 |
Advances in the pathogenesis and treatment of thyroid cancer
NN Hanna, PC McGrath, DA Sloan, DE Kenady |
Current Opinion in Oncology | 1999 |
p53 mutations in tumors derived from irradiated human thyroid epithelial cells
SC Gamble, MC Cook, AC Riches, Z Herceg, PE Bryant, JE Arrand |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 1999 |
Mutations of p53 in Thyroid Carcinoma with an Insular Component
Y Takeuchi, T Daa, K Kashima, S Yokoyama, I Nakayama, S Noguchi |
Thyroid | 1999 |
Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland
J Müller-Höcker |
Human Pathology | 1999 |
Aspectos moleculares do câncer tiroideano
N Barril, EH Tajara |
Arquivos brasileiros de endocrinologia e metabologia | 1999 |
Genetic analysis and clinical application in polygenic diseases. Genetic alterations in thyroid carcinomas
Y Kitamura, K Shimizu, S Tanaka, M Emi |
Nippon Ika Daigaku Zasshi | 1999 |
Molecular and Cellular Pediatric Endocrinology
S Handwerger |
1999 | |
Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression
Moore, Ohene-Fianko, Garcia, Chakrabarti |
Histopathology | 1998 |
Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density
JD Goldenberg, LG Portugal, BL Wenig, K Ferrer, JC Wu, J Sabnani |
Head & Neck | 1998 |
Radioiodine-induced thyroid cancer: Studies in the aftermath of the accident at Chernobyl
J Robbins, AB Schneider |
Trends in Endocrinology & Metabolism | 1998 |
Prognostic Factors in Papillary and Follicular Thyroid Carcinomas
C Godballe, P Asschenfeldt, KE Jørgensen, L Bastholt, PP Clausen, TP Hansen, O Hansen, SM Bentzen |
The Laryngoscope | 1998 |
Transforming Growth Factor-β1 Resistance in a Thyroid Cancer Model of Tumor Necrosis Factor-α Resistance
XP Pang, JM Hershman |
Thyroid | 1998 |
Expression of BCL-2 and p53 in oncocytic (Hürthle cell) tumors of the thyroid: An immunohistochemical study
A Kohli, SP Baker, NA Patwardhan, A Khan |
Endocrine Pathology | 1998 |
THYROID CANCER: PREDISPOSING CONDITIONS, GROWTH FACTORS, SIGNAL TRANSDUCTION AND ONCOGENES
OH Clark |
ANZ Journal of Surgery | 1998 |
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
R Lupetti, P Pisarra, A Verrecchia, C Farina, G Nicolini, A Anichini, C Bordignon, M Sensi, G Parmiani, C Traversari |
Journal of Experimental Medicine | 1998 |
Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma
C Lavarino, V Corletto, A Mezzelani, GD Torre, C Bartoli, C Riva, MA Pierotti, F Rilke, S Pilotti |
British Journal of Cancer | 1998 |
Limited Role of TP53 and TP53-Related Genes in Myxoid Liposarcoma
S Pilotti, C Lavarino, A Mezzelani, GD Torre, F Minoletti, G Sozzi, A Azzarelli, F Rilke, MA Pierotti |
TUMORI | 1998 |
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas
R Elisei, M Shiohara, HP Koeffler, JA Fagin |
Cancer | 1998 |
Effects of p53-Expressing Adenovirus on the Chemosensitivity and Differentiation of Anaplastic Thyroid Cancer Cells
MV Blagosklonny, P Giannakakou, M Wojtowicz, LY Romanova, KB Ain, SE Bates, T Fojo |
The Journal of clinical endocrinology and metabolism | 1998 |
Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior
SA Hosal, RL Apel, JL Freeman, A Azadian, IB Rosen, VA LiVolsi, SL Asa |
Endocrine Pathology | 1997 |
DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS
S Pilotti, GD Torre, C Lavarino, SD Palma, G Sozzi, F Minoletti, S Rao, G Pasquini, A Azzarelli, F Rilke, MA Pierotti |
The Journal of Pathology | 1997 |
Detection of p53 point mutations by double-gradient, denaturing gradient gel electrophoresis
C Gelfi, SC Righetti, F Zunino, GD Torre, MA Pierotti, PG Righetti |
Electrophoresis | 1997 |
Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes
V Pensotti, P Radice, S Presciuttini, D Calistri, I Gazzoli, AP Perez, P Mondini, G Buonsanti, P Sala, C Rossetti, GN Ranzani, L Bertario, MA Pierotti |
Genes, Chromosomes and Cancer | 1997 |
No association between immunohistochemical expression of p53, c-erbB-2, Ki-67, estrogen and progesterone receptors in female papillary thyroid cancer and ionizing radiation
MG Karlsson, L Hardell, A Hallquist |
Cancer Letters | 1997 |
Involvement of p53 in cell differentiation and development
N Almog, V Rotter |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 1997 |
p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy
R Schneider-Stock, K Radig, Y Oda, W Mellin, J Rys, A Niezabitowski, A Roessner |
Journal of Cancer Research and Clinical Oncology | 1997 |
Thyroid Pathology
KW Schmid, W Böcker |
1997 | |
Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma: A molecular-pathological and immunohistochemical study on paraffin-embedded tissue
KW Schmid, A Bankfalvi, S Mücke, D Öfner, K Riehemann, S Schröder, A Stücker, M Tötsch, B Dockhorn-Dworniczak |
Endocrine Pathology | 1996 |
Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells
MA Pierotti, I Bongarzone, MG Borrello, A Greco, S Pilotti, G Sozzi |
Genes, Chromosomes and Cancer | 1996 |
Lack of p16/CDKN2 alterations in thyroid carcinomas
K Yane, N Konishi, Y Kitahori, H Naito, K Okaichi, T Ohnishi, H Miyahara, T Matsunaga, Y Hiasa |
Cancer Letters | 1996 |
A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer
PE Goretzki, V Gorelov, C Dotzenrath, J Witte, HD Roeher |
Surgery | 1996 |
Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer
T Nishida, K Nakao, M Hamaji, M Nakahara, M Tsujimoto |
Surgery | 1996 |
High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines
CJ Jones, JJ Shaw, FS Wyllie, N Gaillard, M Schlumberger, D Wynford-Thomas |
Molecular and Cellular Endocrinology | 1996 |
Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progression
JP Blaydes, D Wynford-Thomas |
International Journal of Cancer | 1996 |
Poorly differentiated carcinomas of the thyroid
M Sobrinho-Simões |
Endocrine Pathology | 1996 |
p53 gene mutation in thyroid carcinoma
YS Ho, SC Tseng, TY Chin, LL Hsieh, JD Lin |
Cancer Letters | 1996 |
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
Y Ito, T Kobayashi, T Takeda, Y Komoike, E Wakasugi, Y Tamaki, M Tsujimoto, N Matsuura, M Monden |
British Journal of Cancer | 1996 |
p53 in a Thyroid Follicular Carcinoma with Foci of Poorly Differentiated and Anaplastic Carcinoma
X Matias-Guiu, A Villanueva, M Cuatrecasas, G Capella, A De_leiva, J Prat |
Pathology - Research and Practice | 1996 |
Critical Commentary
HR Harach |
Pathology - Research and Practice | 1996 |
P53 overexpression in head and neck carcinoma and radiotherapy results
S Awwad, E Jaros, J Somes, J Lunec |
International journal of radiation oncology, biology, physics | 1996 |
Alterations of p53 and Expression of WAF1/p21 in Human Thyroid Tumors
J Zedenius, C Larsson, G Wallin, M Bäckdahl, U Aspenblad, A Höög, AL Børresen, G Auer |
Thyroid | 1996 |
Does telomere shortening drive selection forp53 mutation in human cancer?
E Bresnick, NH Colburn, H Moses, D Wynford-Thomas, JA Bond, FS Wyllie, CJ Jones |
Molecular Carcinogenesis | 1995 |
Recent Advances in Cytometry, Cytogenetics and Molecular Genetics of Thyroid Tumours and Tumour-like Lesions
P Soares, M Sobrinho-Simões |
Pathology - Research and Practice | 1995 |
Evaluation and Management of the Solid Thyroid Nodule
HB Burch |
Endocrinology and metabolism clinics of North America | 1995 |
Allelotyping of follicular thyroid tumors
J Zedenius, G Wallin, A Svensson, L Grimelius, A Hg, G Lundell, M Bckdahl, C Larsson |
Human Genetics | 1995 |
Genetics of Follicular Thyroid Cancer
NR Farid, M Zou, Y Shi |
Endocrinology and metabolism clinics of North America | 1995 |
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas
L Papi, LR Vitis, F Vitelli, E Montali, U Bigozzi, F Ammannati, P Mennonna |
Human Genetics | 1995 |
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
R Holm, JM Nesland |
The Journal of Pathology | 1994 |
p53 Protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland
W Czyz, H Joensuu, L Pylkkänen, PJ Klemi |
The Journal of Pathology | 1994 |
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
S Pilotti, P Collini, F Rilke, G Cattoretti, RD Bo, MA Pierotti |
The Journal of Pathology | 1994 |
Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
P Soares, J Cameselle-Teijeiro, M Sobrinho-Simões |
Histopathology | 1994 |
Analysis of adenomatous polyposis coli gene in thyroid tumours
G Colletta, S Sciacchitano, R Palmirotta, A Ranieri, E Zanella, A Cama, RM Costantini, P Battista, A Pontecorvi |
British Journal of Cancer | 1994 |
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
G Manenti, S Pilotti, FC Re, GD Porta, MA Pierotti |
European Journal of Cancer | 1994 |
Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma
K Iyota, K Takeda, F Matsuzuka, T Okabayashi, S Morita, K Kuma, K Hashimoto |
Journal of Endocrinological Investigation | 1994 |
p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas
X Matias-Guiu, M Cuatrecasas, E Musulen, J Prat |
Journal of clinical pathology | 1994 |
Nongenotoxic Carcinogenesis
A Cockburn, L Smith |
1994 | |
Invited commentary
PJ Kozinn |
World Journal of Surgery | 1980 |